Gill, J. & Gorlick, R. Advancing therapy for osteosarcoma. Nat. Rev. Clin. Oncol. 18, 609–624 (2021).
Yang, C. et al. Bone microenvironment and osteosarcoma metastasis. Int. J. Mol. Sci. 21, 6985 (2020).
Article CAS PubMed PubMed Central Google Scholar
Fletcher, C. D., Unni, K. K., & Mertens, F. (Eds.). (2002). Pathology and genetics of tumours of soft tissue and bone (Vol. 4). Iarc.
Messerschmitt, P. J., Garcia, R. M., Abdul-Karim, F. W., Greenfield, E. M. & Getty, P. J. Osteosarcoma. JAAOS - J. Am. Acad. Orthop. Surg. 17, 515–527 (2009).
Fox, M. G. & Trotta, B. M. Osteosarcoma: review of the various types with emphasis on recent advancements in imaging. Semin. Musculoskelet. Radio. 17, 123–136 (2013).
Smrke, A. et al. Future directions in the treatment of osteosarcoma. Cells 10, 172 (2021).
Article CAS PubMed PubMed Central Google Scholar
Corre, I., Verrecchia, F., Crenn, V., Redini, F. & Trichet, V. The osteosarcoma microenvironment: a complex but targetable ecosystem. Cells 9, 976 (2020).
Article CAS PubMed PubMed Central Google Scholar
Gaspar, N. et al. Recent advances in understanding osteosarcoma and emerging therapies. Faculty Rev. 9, 18 (2020).
Cascini, C. & Chiodoni, C. The immune landscape of osteosarcoma: implications for prognosis and treatment response. Cells 10, 1668 (2021).
Article CAS PubMed PubMed Central Google Scholar
Meazza, C. & Scanagatta, P. Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Rev. Anticancer Ther. 16, 543–556 (2016).
Article CAS PubMed Google Scholar
Xiao, X., Wang, W. & Wang, Z. The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma. Paediatr. Drugs 16, 503–512 (2014).
Hu, Z. et al. Current status and prospects of targeted therapy for osteosarcoma. Cells 11, 3507 (2022).
Article CAS PubMed PubMed Central Google Scholar
Supra, R. & Agrawal, D. K. Immunotherapeutic strategies in the management of osteosarcoma. J. Orthop. Sports Med. 5, 32–40 (2023).
Article PubMed PubMed Central Google Scholar
Yahiro, K. & Matsumoto, Y. Immunotherapy for osteosarcoma. Hum. Vaccin Immunother. 17, 1294–1295 (2021).
Article CAS PubMed Google Scholar
Park, J. A. & Cheung, N. V. Promise and challenges of T cell immunotherapy for osteosarcoma. Int. J. Mol. Sci. 24, 12520 (2023).
Article CAS PubMed PubMed Central Google Scholar
Nirala, B. K., Yamamichi, T., Petrescu, D. I., Shafin, T. N. & Yustein, J. T. Decoding the impact of tumor microenvironment in osteosarcoma progression and metastasis. Cancers (Basel) 15, 5108 (2023).
Article CAS PubMed Google Scholar
Zhu, T. et al. Immune microenvironment in osteosarcoma: components, therapeutic strategies and clinical applications. Front. Immunol. 13, 907550 (2022).
Article CAS PubMed PubMed Central Google Scholar
Tian, H. et al. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment. Bone Res. 11, 11 (2023).
Article CAS PubMed PubMed Central Google Scholar
Guo, J. et al. Single-cell profiling of tumor microenvironment heterogeneity in osteosarcoma identifies a highly invasive subcluster for predicting prognosis. Front. Oncol. 12, 732862 (2022).
Article CAS PubMed PubMed Central Google Scholar
Huang, R. et al. Combining bulk RNA-sequencing and single-cell RNA-sequencing data to reveal the immune microenvironment and metabolic pattern of osteosarcoma. Front. Genet. 13, 976990 (2022).
Article CAS PubMed PubMed Central Google Scholar
Huang, X., Wang, L., Guo, H., Zhang, W. & Shao, Z. Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma. Theranostics 12, 5877–5887 (2022).
Article CAS PubMed PubMed Central Google Scholar
Liu, Y. et al. Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma. Front. Oncol. 11, 709210 (2021).
Article CAS PubMed PubMed Central Google Scholar
Liu, W. et al. Characterizing the tumor microenvironment at the single-cell level reveals a novel immune evasion mechanism in osteosarcoma. Bone Res. 11, 4 (2023).
Article CAS PubMed PubMed Central Google Scholar
Thomas, D. D., Lacinski, R. A. & Lindsey, B. A. Single-cell RNA-seq reveals intratumoral heterogeneity in osteosarcoma patients: a review. J. Bone Oncol. 39, 100475 (2023).
Article PubMed PubMed Central Google Scholar
Zhong, C. et al. Single-cell and bulk RNA sequencing reveals Anoikis related genes to guide prognosis and immunotherapy in osteosarcoma. Sci. Rep. 13, 20203 (2023).
Article PubMed PubMed Central Google Scholar
Zhou, Y. et al. Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. Nat. Commun. 11, 6322 (2020).
Article CAS PubMed PubMed Central Google Scholar
Evdokimova, V., Gassmann, H., Radvanyi, L. & Burdach, S. E. G. Current state of immunotherapy and mechanisms of immune evasion in ewing sarcoma and osteosarcoma. Cancers (Basel) 15, 272 (2022).
Ligon, J. A. et al. Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes. J. Immunother. Cancer 9, e001772 (2021).
Article PubMed PubMed Central Google Scholar
Cillo, A. R. et al. Ewing sarcoma and osteosarcoma have distinct immune signatures and intercellular communication networks. Clin. Cancer Res. 28, 4968–4982 (2022).
Article CAS PubMed PubMed Central Google Scholar
Bressan, D., Battistoni, G. & Hannon, G. J. The dawn of spatial omics. Science 381, eabq4964 (2023).
Article CAS PubMed PubMed Central Google Scholar
Black, S. et al. CODEX multiplexed tissue imaging with DNA-conjugated antibodies. Nat. Protoc. 16, 3802–3835 (2021).
Article CAS PubMed PubMed Central Google Scholar
Goltsev, Y. et al. Deep profiling of mouse splenic architecture with CODEX multiplexed imaging. Cell 174, 968–981.e915 (2018).
Comments (0)